3'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)acetanilide>98.0%(GC)(T)1g

3,6-Diphenylpyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione, 95.0%, 25g

6-Amino-2-(butylamino)-9-[[6-[2-(dimethylamino)ethoxy]-3-pyridinyl]methyl]-7,9-dihydro-8H-purin-8-one, 25mg

7-Bromo-4-methoxyquinoline, 95.0%, 25g

1-(1-benzyl-4-hydroxy-1,2,5,6-tetrahydropyridin-3-yl)-2,2,2-trifluoroethan-1-one hydrochloride, 98%, 10g

4-Chloro-3-methyl-1-tosyl-1H-pyrrolo[2,3-b]pyridine, 97%, 250mg

N-(4-Formyl-2-nitrophenyl)acetamide, 100mg

1-[(tert-Butoxy)carbonyl]-4-(trifluoromethyl)piperidine-4-carboxylic acid, 98%, 5g

5-Amino-3,6-dichloropyrazine-2-carboxylic acid, 95.0%, 250mg

Medical couch SÖHNGEN®, adjustable head section, rigid foot section, 1 piece

Glycine, min. 99%, for synthesis, 10 kg, plastic packaging.

7-Bromo-4H-pyrido[1,2-a]pyrimidin-4-one, 95.0%, 25g

4-(2-Bromo-5-hydroxybenzyl)morpholine, 95+%, 500mg